These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38520925)

  • 1. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts.
    van Geffen EGM; Langhout JMA; Hazen SJA; Sluckin TC; van Dieren S; Beets GL; Beets-Tan RGH; Borstlap WAA; Burger JWA; Horsthuis K; Intven MPW; Aalbers AGJ; Havenga K; Marinelli AWKS; Melenhorst J; Nederend J; Peulen HMU; Rutten HJT; Schreurs WH; Tuynman JB; Verhoef C; de Wilt JHW; Marijnen CAM; Tanis PJ; Kusters M; On Behalf Of The Dutch Snapshot Research Group
    Eur J Cancer; 2024 May; 202():114021. PubMed ID: 38520925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally Recurrent Rectal Cancer: Toward a Second Chance at Cure? A Population-Based, Retrospective Cohort Study.
    Swartjes H; van Rees JM; van Erning FN; Verheij M; Verhoef C; de Wilt JHW; Vissers PAJ; Koëter T
    Ann Surg Oncol; 2023 Jul; 30(7):3915-3924. PubMed ID: 36790731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Nordenvall C; Johansson H; Holm T; Martling A
    Br J Surg; 2017 Dec; 104(13):1866-1873. PubMed ID: 29023631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results.
    Sorrentino L; Belli F; Valvo F; Villa S; Guaglio M; Scaramuzza D; Gronchi A; Di Bartolomeo M; Cosimelli M
    Surg Oncol; 2020 Dec; 35():89-96. PubMed ID: 32858390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a history of metastases or synchronous metastases on survival in patients with locally recurrent rectal cancer.
    Voogt ELK; van Zoggel DMGI; Kusters M; Nieuwenhuijzen GAP; Cnossen JS; Creemers GJ; van Lijnschoten G; Nederend J; Roef MJ; Burger JWA; Rutten HJT
    Colorectal Dis; 2021 May; 23(5):1120-1131. PubMed ID: 33474793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?
    van Rees JM; Nordkamp S; Harmsen PW; Rutten H; Burger JWA; Verhoef C
    Eur J Surg Oncol; 2023 Sep; 49(9):106865. PubMed ID: 37002176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
    van Ham NCM; Glazemakers S; van der Ende-van Loon M; Nieuwenhuijzen GAP; Rutten HJT; Tolenaar JL; Jacobs A; Burger JWA; Ketelaers SHJ; Bloemen JG
    Eur J Surg Oncol; 2024 Jun; 50(6):108259. PubMed ID: 38552415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgery for locally recurrent and second recurrent rectal cancer with metastatic disease.
    Tanaka A; Uehara K; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Surg Oncol; 2020 Dec; 35():328-335. PubMed ID: 32979698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer.
    Dresen RC; Gosens MJ; Martijn H; Nieuwenhuijzen GA; Creemers GJ; Daniels-Gooszen AW; van den Brule AJ; van den Berg HA; Rutten HJ
    Ann Surg Oncol; 2008 Jul; 15(7):1937-47. PubMed ID: 18389321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review.
    Fadel MG; Ahmed M; Malietzis G; Pellino G; Rasheed S; Brown G; Tekkis P; Kontovounisios C
    Cancer Treat Rev; 2022 Sep; 109():102419. PubMed ID: 35714574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.
    Selvaggi F; Fucini C; Pellino G; Sciaudone G; Maretto I; Mondi I; Bartolini N; Caminati F; Pucciarelli S
    Tech Coloproctol; 2015 Mar; 19(3):135-44. PubMed ID: 25384359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 19. Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre.
    Hagemans JAW; van Rees JM; Alberda WJ; Rothbarth J; Nuyttens JJME; van Meerten E; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2020 Mar; 46(3):448-454. PubMed ID: 31761506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.
    Holman FA; Bosman SJ; Haddock MG; Gunderson LL; Kusters M; Nieuwenhuijzen GA; van den Berg H; Nelson H; Rutten HJ
    Eur J Surg Oncol; 2017 Jan; 43(1):107-117. PubMed ID: 27659000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.